REBECCA BYAM: Open Payments
NPI 1437824042 · MIDDLETOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$160 in 7 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $123 · 2025 $160
Food & beverage: $160
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| ABBVIE INC. | 2 | $47 |
| GENZYME CORPORATION | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: ENTYVIO, RINVOQ, DUPIXENT, XIFAXAN.
Industry payments across NY — which companies pay providers there.
